Iteos Therapeutics Inc (ITOS) — Capital Reinvestment Ratio

Latest as of December 2024: 0.03x

Iteos Therapeutics Inc (ITOS) has a Capital Reinvestment Ratio of 0.03x as of December 2024, meaning it reinvests 0% of its operating cash flow ($5.50 Million) in capital expenditures ($152.00K). Check ITOS intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.03x

Capex / Operating Cash Flow

Operating Cash Flow

$5.50 Million

USD

Capital Expenditures

$152.00K

USD

Data as of

Dec 2024

Most recent filing

Iteos Therapeutics Inc Capital Reinvestment Ratio (2021–2021)

This chart tracks Iteos Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Iteos Therapeutics Inc (ITOS) cash flow conversion.

Annual Capital Reinvestment Ratio for Iteos Therapeutics Inc (2021–2021)

Year-by-year Capital Reinvestment Ratio for Iteos Therapeutics Inc from 2021 to 2021. See how much free cash does Iteos Therapeutics Inc generate to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change
2021	0.00x	$513.14 Million	$1.18 Million	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow